Masimo PVI™ Cleared for Market in Japan

AARC Corporate Partner, Masimo, recently announced that the Masimo PVT™ has been cleared for market in Japan by the Japanese Ministry of Health.

PVI is an index automatically derived from the Masimo plethysmographic waveform, which has been demonstrated to noninvasively assess fluid responsiveness in mechanically ventilated patients and can help clinicians assess if a patient's cardiac function is compromised.

Masimo joined the AARC Corporate Partner Program in 2003. The AARC's Corporate Partner Program is comprised of best-in-class organizations interested in supporting the goals and work of the Association.